Sarbecovirus Disease Susceptibility is Conserved Across Viral and Host Models

Overview

Journal Virus Res

Specialty Microbiology

Date 2024 Jun 1

PMID 38823688

Authors

Sarah R Leist

Alexandra Schafer

Ellen L Risemberg

Timothy A Bell

Pablo Hock

Mark R Zweigart

Colton L Linnertz

Darla R Miller

Ginger D Shaw

Fernando Pardo Manuel de Villena

Martin T Ferris

William Valdar

Ralph S Baric

Affiliations

Soon will be listed here.

Abstract

Coronaviruses have caused three severe epidemics since the start of the 21 century: SARS, MERS and COVID-19. The severity of the ongoing COVID-19 pandemic and increasing likelihood of future coronavirus outbreaks motivates greater understanding of factors leading to severe coronavirus disease. We screened ten strains from the Collaborative Cross mouse genetic reference panel and identified strains CC006/TauUnc (CC006) and CC044/Unc (CC044) as coronavirus-susceptible and resistant, respectively, as indicated by variable weight loss and lung congestion scores four days post-infection. We generated a genetic mapping population of 755 CC006xCC044 F2 mice and exposed the mice to one of three genetically distinct mouse-adapted coronaviruses: clade 1a SARS-CoV MA15 (n=391), clade 1b SARS-CoV-2 MA10 (n=274), and clade 2 HKU3-CoV MA (n=90). Quantitative trait loci (QTL) mapping in SARS-CoV MA15- and SARS-CoV-2 MA10-infected F2 mice identified genetic loci associated with disease severity. Specifically, we identified seven loci associated with variation in outcome following infection with either virus, including one, HrS43, that is present in both groups. Three of these QTL, including HrS43, were also associated with HKU3-CoV MA outcome. HrS43 overlaps with a QTL previously reported by our lab that is associated with SARS-CoV MA15 outcome in CC011xCC074 F2 mice and is also syntenic with a human chromosomal region associated with severe COVID-19 outcomes in humans GWAS. The results reported here provide: (a) additional support for the involvement of this locus in SARS-CoV MA15 infection, (b) the first conclusive evidence that this locus is associated with susceptibility across the Sarbecovirus subgenus, and (c) demonstration of the relevance of mouse models in the study of coronavirus disease susceptibility in humans.

References

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Leist S, Dinnon 3rd K, Schafer A, Tse L, Okuda K, Hou Y . A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell. 2020; 183(4):1070-1085.e12. PMC: 7510428. DOI: 10.1016/j.cell.2020.09.050. View

Maurizio P, Ferris M, Keele G, Miller D, Shaw G, Whitmore A . Bayesian Diallel Analysis Reveals -Dependent and -Independent Effects on Response to Influenza A Virus in Mice. G3 (Bethesda). 2017; 8(2):427-445. PMC: 5919740. DOI: 10.1534/g3.117.300438. View

Gralinski L, Menachery V, Morgan A, Totura A, Beall A, Kocher J . Allelic Variation in the Toll-Like Receptor Adaptor Protein Contributes to SARS-Coronavirus Pathogenesis in Mice. G3 (Bethesda). 2017; 7(6):1653-1663. PMC: 5473747. DOI: 10.1534/g3.117.041434. View

Smith C, Proulx M, Olive A, Laddy D, Mishra B, Moss C . Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype. mBio. 2016; 7(5). PMC: 5030360. DOI: 10.1128/mBio.01516-16. View

Adams L, Leist S, Dinnon 3rd K, West A, Gully K, Anderson E . Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination. Cell Rep. 2023; 42(4):112326. PMC: 10063157. DOI: 10.1016/j.celrep.2023.112326. View

Becker M, Graham R, Donaldson E, Rockx B, Sims A, Sheahan T . Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci U S A. 2008; 105(50):19944-9. PMC: 2588415. DOI: 10.1073/pnas.0808116105. View

Ferris M, Aylor D, Bottomly D, Whitmore A, Aicher L, Bell T . Modeling host genetic regulation of influenza pathogenesis in the collaborative cross. PLoS Pathog. 2013; 9(2):e1003196. PMC: 3585141. DOI: 10.1371/journal.ppat.1003196. View

Roberts A, Deming D, Paddock C, Cheng A, Yount B, Vogel L . A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 2007; 3(1):e5. PMC: 1769406. DOI: 10.1371/journal.ppat.0030005. View

10.

Gralinski L, Bankhead 3rd A, Jeng S, Menachery V, Proll S, Belisle S . Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio. 2013; 4(4). PMC: 3747576. DOI: 10.1128/mBio.00271-13. View

11.

Shelton J, Shastri A, Ye C, Weldon C, Filshtein-Sonmez T, Coker D . Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat Genet. 2021; 53(6):801-808. DOI: 10.1038/s41588-021-00854-7. View

12.

Zhang P, Philippot Q, Ren W, Lei W, Li J, Stenson P . Genome-wide detection of human variants that disrupt intronic branchpoints. Proc Natl Acad Sci U S A. 2022; 119(44):e2211194119. PMC: 9636908. DOI: 10.1073/pnas.2211194119. View

13.

Ohtsuka N, Taguchi F . Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. J Virol. 1997; 71(11):8860-3. PMC: 192354. DOI: 10.1128/JVI.71.11.8860-8863.1997. View

14.

Threadgill D, Miller D, Churchill G, Pardo-Manuel de Villena F . The collaborative cross: a recombinant inbred mouse population for the systems genetic era. ILAR J. 2011; 52(1):24-31. DOI: 10.1093/ilar.52.1.24. View

15.

Pfaender S, Mar K, Michailidis E, Kratzel A, Boys I, Vkovski P . LY6E impairs coronavirus fusion and confers immune control of viral disease. Nat Microbiol. 2020; 5(11):1330-1339. PMC: 7916999. DOI: 10.1038/s41564-020-0769-y. View

16.

Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P . Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020; 383(16):1522-1534. PMC: 7315890. DOI: 10.1056/NEJMoa2020283. View

17.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

18.

Gralinski L, Ferris M, Aylor D, Whitmore A, Green R, Frieman M . Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross. PLoS Genet. 2015; 11(10):e1005504. PMC: 4599853. DOI: 10.1371/journal.pgen.1005504. View

19.

Broman K, Wu H, Sen S, Churchill G . R/qtl: QTL mapping in experimental crosses. Bioinformatics. 2003; 19(7):889-90. DOI: 10.1093/bioinformatics/btg112. View

20.

Leist S, Baric R . Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections. Trends Genet. 2018; 34(10):777-789. PMC: 7114642. DOI: 10.1016/j.tig.2018.07.005. View